Since the Enterprise Investment Scheme (EIS) was launched in 1994 thousands of small UK companies have used the government boon to raise growth capital for their businesses. According to HMRC statistics, in the 2017-18 tax year 3,920 companies raised a total of £1.93 billion of funds under EIS. Since launch, that took the total number […]
Want to save on your tax bill and invest in growing companies at the same time? With a range of government backed incentive schemes you can do exactly that. Small businesses are the lifeblood of the UK economy. They employ an estimated 16 million people (more than half of the workforce), account for 99.3% of […]
You might think that with the budget of last week, it is all gloom for non-doms. However, it would pay to revisit a previous government initiative.
On 6 April 2012, the government introduced the very attractive Business Investment Relief (“BIR”) for non-UK domiciliaries. This is relevant if you are currently a resident in the UK, are treated for tax purposes as non- domiciled (non-dom), and have overseas income and gains.
On the first glance, It does not seem likely that the UK government would be that generous with its revenue. Nevertheless, these tax reliefs are available to investors in certain instances.
To be eligible for the relief, the company seeking the investment must have:
1. A permanent establishment in the UK for a period of 3 years from the issue of the shares.
2. All the money raised by the share issue must be used within two years in a ‘qualifying trade.’
3. The trade must be carried on by the parent company or subsidiary which is a 90% subsidiary for a period of 3 years from the issue of the shares.
Tony De Nazareth, who has over 30 years’ experience in investment banking, venture capital and lending, has launched Crowd for Angels, a platform to provide funding for companies from the beginning till it is listed. The launch pitches include film company, The Series Ltd, which is looking to raise funds for TV drama, the Mughals, Bet Fast Ltd, a mobile software company and AIM listed company Advanced Oncotherapy, a provider of radiotherapy systems, which has a £22.7 m market cap and recently raised £6 m through traditional channels.
It is launched by Tony De Nazareth who has over 30 years’ experience of investment banking, venture capital and lending. He has combined his experience and knowledge of finance with his interest in social media and technology to create an innovative source of funding that competes with, and has the potential to replace the traditional sources of funding for companies.